Strengthening primary health care through FHN: randomized controlled trial on HbA1c reduction in middle aged women with T2DM in Iran
4 affiliations
- 1Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
- 2Department of Community Health and Gerontological Nursing, Faculty of Nursing and Midwifery, Nursing and Midwifery Care Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran
- 3Department of Community Health and Gerontological Nursing, Faculty of Nursing and Midwifery, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran
- 4Department of Community and Family Medicine, School of Medicine and Child Growth and Development Research Center Group, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Introduction: T2DM is a prevalent, non-communicable, and manageable disease worldwide. Patient empowerment in self-care and family support for self-management are crucial in controlling this condition. FHN aim to manage chronic diseases through a family centered approach by implementing necessary measures.
Methods: This study employed a two-group, three stage clinical trial method, focusing on middle-aged women with T2DM from selected comprehensive health service centers in Isfahan. A total of 84 middle-aged women with T2DM were selected through systematic sampling and a random number table. The experimental group completed a consent form, a demographic questionnaire, and an Hba1c test before the intervention, and repeated the Hba1c test three months post-intervention. The intervention group underwent the FHN model intervention, conducted in three stages: providing services tailored to the patient's actual needs, coordinating the use of all available health service resources, and empowering the family. Independent t-tests and repeated-measures analysis of variance with LSD post hoc test were used to compare the groups, and data analysis was performed using SPSS version 26 software.
Findings: The findings indicated that the implementation of the FHN model significantly reduced the HbA1c score in the intervention group compared to the control group three months after the intervention (p<0.05).
Conclusion: The results suggest that the FHN model is an effective, low-cost, and accessible approach for controlling Hba1c in patients with T2DM.
Trial registration: The study was registered as a randomized controlled trial in the Clinical Trial Registration Center of Iran (Registration Date: 2023-07-26; Registration Number: IRCT20230522058256N1). https://irct.behdasht.gov.ir/user/trial/68288/view.
Related
- Effects of grip strengthening combined with scapular stabilization exercise on shoulder muscle strength and functional outcomes in individuals with subacromial pain syndrome : A randomized controlled trial
- Efficacy and safety of spleen-strengthening and phlegm-resolving herbal therapy for residual dizziness after repositioning of benign paroxysmal positional vertigo: a systematic review and meta-analysis of randomized controlled trials
- Effects of vastus medialis oblique-focused and general quadriceps strengthening exercises on Q-angle and quadriceps strength in overweight and obese females: A randomized controlled trial
- Blood Biomarkers of Alzheimer's Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial
- Participant Characteristics Associated With Loneliness Reduction During a Digital Social Robot Intervention Among Older Adults Living Alone in Japan: Secondary Analysis of a Randomized Controlled Trial
BibTeX
@article{noorollahi2026strengthening,
title = {{Strengthening primary health care through FHN: randomized controlled trial on HbA1c reduction in middle aged women with T2DM in Iran}},
author = {Zohreh Noorollahi and Tayebeh Karimi and Mahrokh Keshvari and Azam Esmaeili and Ziba Fajzadegan},
journal = {BMC Nursing},
year = {2026},
month = aug,
doi = {10.1186/s12912-026-05194-7},
url = {https://doi.org/10.1186/s12912-026-05194-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Strengthening primary health care through FHN: randomized controlled trial on HbA1c reduction in middle aged women with T2DM in Iran
AU - Zohreh Noorollahi
AU - Tayebeh Karimi
AU - Mahrokh Keshvari
AU - Azam Esmaeili
AU - Ziba Fajzadegan
PY - 2026
DA - 2026/08/08
JO - BMC Nursing
DO - 10.1186/s12912-026-05194-7
UR - https://doi.org/10.1186/s12912-026-05194-7
AB - Introduction: T2DM is a prevalent, non-communicable, and manageable disease worldwide. Patient empowerment in self-care and family support for self-management are crucial in controlling this condition. FHN aim to manage chronic diseases through a family centered approach by implementing necessary measures. Methods: This study employed a two-group, three stage clinical trial method, focusing on middle-aged women with T2DM from selected comprehensive health service centers in Isfahan. A total of 84 middle-aged women with T2DM were selected through systematic sampling and a random number table. The experimental group completed a consent form, a demographic questionnaire, and an Hba1c test before the intervention, and repeated the Hba1c test three months post-intervention. The intervention group underwent the FHN model intervention, conducted in three stages: providing services tailored to the patient's actual needs, coordinating the use of all available health service resources, and empowering the family. Independent t-tests and repeated-measures analysis of variance with LSD post hoc test were used to compare the groups, and data analysis was performed using SPSS version 26 software. Findings: The findings indicated that the implementation of the FHN model significantly reduced the HbA1c score in the intervention group compared to the control group three months after the intervention (p<0.05). Conclusion: The results suggest that the FHN model is an effective, low-cost, and accessible approach for controlling Hba1c in patients with T2DM. Trial registration: The study was registered as a randomized controlled trial in the Clinical Trial Registration Center of Iran (Registration Date: 2023-07-26; Registration Number: IRCT20230522058256N1). https://irct.behdasht.gov.ir/user/trial/68288/view.
SN - 1472-6955
ER -